Antibiotic resistant superbugs: Assessment of the interrelationship of occurrence in clinical settings and environmental niches

Molecules

Volumn 22, Issue 1, 2017, Pages

  Adegoke, Anthony Ayodeji ^a,b,c   Faleye, Adekunle Christopher ^a   Singh, Gulshan ^a   Stenström, Thor Axel ^a  

^a DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^b UNIVERSITY OF UYO   (Nigeria)

^c UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Antimicrobial Resistance; Critical Control Point; Exposure; Health Risk Assessment; Residual Antibiotics; Superbug; Total Antibiotic Resistance

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIUM; DRUG EFFECTS; ENVIRONMENT; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENT; HUMANS; MICROBIAL SENSITIVITY TESTS; SOIL MICROBIOLOGY; WATER MICROBIOLOGY;

EID: 85009516114     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22010029     Document Type: Review

References (170)

1. Rizzo, L.; Manaia, C.; Merlin, C.; Schwartz, T.; Dagot, C.; Ploy, M.C.; Michael, I.; Fatta-Kassinos, D. Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review. Sci. Total Environ. 2013, 447, 345-360.
2. Bérdy, J. Bioactive microbial metabolites. J. Antibiot. 2005, 58, 1-26.
3. Gros, M.; Petrovíc, M.; Barceló, D. Multi-residue analytical methods using LC-Tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: A review. Anal. Bioanal. Chem. 2006, 386, 941-952.
4. Segura, P.A.; François, M.; Gagnon, C.; Sauvé, S. Review of the occurrence of anti-infectives in contaminated wastewaters and natural drinking waters. Environ. Health Perspect. 2009, 117, 675-684.
5. Allen, H.K.; Donato, J.; Wang, H.H.; Cloud-Hansen, K.A.; Davies, J.; Handelsman, J. Call of the wild: Antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. 2010, 8, 251-259.
6. DCosta, V.M.; King, C.E.; Kalan, L.; Morar, M.; Sung, W.W.L.; Schwarz, C.; Froese, D.; Zazula, G.; Calmels, F.; Debruyne, R.; et al. Antibiotic resistance is ancient. Nature 2011, 477, 457-461.
7. Forsberg, K.J.; Reyes, A.;Wang, B.; Selleck, E.M.; Sommer, M.O.A.; Dantas, G. The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337, 1107-1111.
8. Hughes, S.R.; Kay, P.; Brown, L.E. Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ. Sci. Technol. 2013, 47, 661-677.
9. Gillings, M.R. Evolutionary consequences of antibiotic use for the resistome, mobilome and microbial pangenome. Front. Microbiol. 2013, 4.
10. Baquero, F.; Martínez, J.L.; Cantón, R. Antibiotics and antibiotic resistance in water environments. Curr. Opin. Biotechnol. 2008, 19, 260-265.
11. Pei, R.; Kim, S.C.; Carlson, K.H.; Pruden, A. Effect of river landscape on the sediment concentrations of antibiotics and corresponding antibiotic resistance genes (ARG). Water Res. 2006, 40, 2427-2435.
12. Pruden, A.; Arabi, M.; Storteboom, H.N. Correlation between upstream human activities and riverine antibiotic resistance genes. Environ. Sci. Technol. 2012, 46, 11541-11549.
13. Khan, G.A.; Berglund, B.; Khan, M.K.; Lindgren, P.E.; Fick, J. Occurrence and abundance of antibiotics and resistance genes in rivers, canal and near drug formulation facilities-A study in Pakistan. PLoS ONE 2013, 8, e62712.
14. Li, D.; Yu, T.; Zhang, Y.; Yang, M.; Li, Z.; Liu, M.; Qi, R. Antibiotic resistance characteristics of environmental bacteria from an oxytetracycline production wastewater treatment plant and the receiving river. Appl. Environ. Microbiol. 2010, 76, 3444-3451.
15. Kristiansson, E.; Fick, J.; Janzon, A.; Grabic, R.; Rutgersson, C.; Weijdegard, B.; Söderström, H.; Joakim Larsson, D.G. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS ONE 2011, 6, e17038.
16. Holmberg, S.D.; Solomon, S.L.; Blake, P.A. Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis. 1987, 9, 1065-1078.
17. Cheng, G.; Hu, Y.; Yin, Y.; Yang, X.; Xiang, C.; Wang, B.; Chen, Y.; Yang, F.; Lei, F.; Wu, N.; et al. Functional screening of antibiotic resistance genes from human gut microbiota reveals a novel gene fusion. FEMS Microbiol. Lett. 2012, 336, 11-16.
18. Gullberg, E.; Cao, S.; Berg, O.G.; Ilbäck, C.; Sandegren, L.; Hughes, D.; Andersson, D.I. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011, 7, e1002158.
19. World Health Organization. Global Action Plan on Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2015.
20. Serrano, P.H. Responsible Use of Antibiotics in Aquaculture; In FAO Fisheries Technical Paper 469 (Rome; United Nations); Food and Agriculture Organization of the United Nations: Rome, Italy, 2005; p. 89.
21. Smith, P.R.; LeBreton, A.; Horsberg, T.E.; Corsin, F. Guidelines for antimicrobial use in aquaculture. In Guide to Antimicrobial Use in Animals; Guardabassi, L., Jensen, L.B., Kruse, H., Eds.; Blackwell Publishing Ltd.: Oxford, UK, 2009; pp. 207-218.
22. Waksman, S.A. Antagonistic relations of microorganisms. Bacteriol. Rev. 1941, 5, 231-291.
23. Lewis, I.M. Bacterial antagonism with special reference to the effect of Pseudomonas fluorescens on spore forming bacteria of soils. J. Bacteriol. 1929, 17, 89-103.
24. Waksman, S.A.;Woodruff, H.B. The soil as a source of microorganisms antagonistic to disease producing bacteria. J. Bacteriol. 1940, 40, 581-600.
25. Florey, H.W. The use of micro-organisms for therapeutic purposes. Yale J. Biol. Med. 1946, 19, 101-117.
26. Smith, T. Antibiotics from soil bacteria. Nat. Struct. Biol. 2000, 7, 189-190.
27. Plough, H.H. Penicillin resistance of Staphylococcus aureus and its clinical implications. Am. J. Clin. Pathol. 1945, 15, 446-451.
28. Cox, G.;Wright, G.D. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int. J. Med. Microbiol. 2013, 303, 287-292.
29. Benveniste, R.; Davies, J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. USA 1973, 70, 2276-2280.
30. Nesme, J.; Cécillon, S.; Delmont, T.O.; Monier, J.-M.; Vogel, T.M.; Simonet, P. Large-scale metagenomics based study of antibiotic resistance in the environment. Curr. Biol. 2014, 10, 1096-1100.
31. Rosenberg, G.; Steinberg, N.; Oppenheimer-Shaanan, N.; Olender, T.; Doron, S.; Ben-Ari, J.; Sirota-Madi, A.; Bloom-Ackermann, Z.; Kolodkin-Gal, I. Not so simple, not so subtle: The interspecies competition between Bacillus simplex and Bacillus subtilis and its impact on the evolution of biofilms. NPJ Biofilms Microbiomes 2016, 2, 15027.
32. Vas-Moreira, I.; Nune, O.C.; Manaia, C.M. Bacterial diversity and antibiotic resistance in water habitats: searching the links with the human microbiome. FEM Microbiol. Rev. 2014, 38, 718-761.
33. Adegoke, A.A.; Awolusi, O.O.; Stenström, T.A. Organic Fertilizers: Public Health Intricacies. In Organic Fertilizers-From Basic Concepts to Applied Outcomes; Larramendy, M., Ed.; INTECH: Vienna, Austria, 2016.
34. McEwen, S.A.; Fedorka-Cray, P.J. Antimicrobial use and resistance in animals. Clin. Infect. Dis. 2002, 34 (Suppl. S3), S93-S106.
35. Butaye, P.; Devriese, L.A.; Haesebrouck, F. Antimicrobial growth promoters used in animal feed: Effects of less well known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev. 2003, 16, 175-188.
36. APUAs International Surveillance of Reservoirs of Resistance (ISRAR) 2008-2010. Available online: http://emerald.tufts.edu/med/apua/research/israr-10-957998750.pdf (accessed on 11 October 2016).
37. Wang, M.; Tang, J.C. Research of antibiotics pollution in soil environments and its ecological toxicity. J. Agro-Environ. Sci. 2010, 29, 261-266.
38. McManus, P.S.; Stockwell, V.O.; Sundin, G.W.; Jones, A.L.Antibiotic use in plant agriculture.Ann. Rev. Phytopathol. 2002, 40, 443-465.
39. Pan, X.; Qiang, Z.M.; Ben, W.W.; Chen, M.X. Residual veterinary antibiotics in swine manure from concentrated animal feeding operations in Shandong Province, China. Chemosphere 2011, 84, 695-700.
40. Cheng, V.C.C.; Wong, S.C.Y.; Ho, P.L.; Yuen, K.Y. Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerg. Microbes Infect. 2015, 4, e8.
41. Pace, N.R. Mapping the tree of life: Progress and prospects. Microbiol. Mol. Biol. Rev. 2009, 73, 565-576.
42. Hussain, M.; Zouhar, M.; Ryšánek, P.; Anwar, S.A. Relationship between meloidogyne incognita density and plant growth of okra. J. Anim. Plant Sci. 2016, 26, 739-744.
43. Zhang, H.; Luo, Y.; Wu, L.; Huang, Y.; Christie, P. Residues and potential ecological risks of veterinary antibiotics in manures and composts associated with protected vegetable farming. Environ. Sci. Pollut. Res. Int. 2015, 22, 5908-5918.
44. Zhang, H.; Zhou, Y.; Huang, Y.; Wu, L.; Liu, X.; Luo, Y. Residues and risks of veterinary antibiotics in protected vegetable soils following application of different manures. Chemosphere 2016, 152, 229-237.
45. Furtula, V.; Farrell, E.G.; Diarrassouba, F.; Rempel, H.; Pritchard, J.; Diarra, M.S. Veterinary pharmaceuticals and antibiotic resistance of Escherichia coli isolates in poultry litter from commercial farms and controlled feeding trials. Poultry Sci. 2010, 89, 180-188.
46. Watkinson, A.J.; Murby, E.J.; Kolpin, D.W.; Costanzo, S.D. The occurrence of antibiotics in an urban watershed: from wastewater to drinking water. Sci. Total Environ. 2009, 407, 2711-2723.
47. Li, D.; Yang, M.; Hu, J.; Zhang, J.; Liu, R.; Gu, X.; Zhang, Y.; Wang, Z. Antibiotic-resistance profile in environmental bacteria isolated from penicillin production wastewater treatment plant and the receiving river. Environ. Microbiol. 2009, 11, 1506-1517.
48. Zuccato, E.; Castiglioni, S.; Fanelli, R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J. Hazard. Mater. 2005, 122, 205-209.
49. Ternes, T.A.; Hirsch, R. Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment. Environ. Sci. Technol. 2000, 34, 2741-2748.
50. Castiglioni, S.; Fanelli, R.; Calamari, D.; Bagnati, R.; Zuccato, E. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy. Regul. Toxicol. Pharmacol. 2004, 39, 25-32.
51. Berto, J.; Rochenbach, G.C.; Barreiros, M.A.B.; Correa, A.X.R.; Peluso-Silva, S.; Radetski, C.M. Physicochemical, microbiological, and ecotoxicological evaluation of a septic tank/Fenton reaction combination for the treatment of hospital wastewaters. Ecotoxicol. Environ. Saf. 2009, 72, 1076-1081.
52. Heuer, H.; Smalla, K. Plasmids foster diversification and adaptation of bacterial populations in soil. FEMS Microbiol. Rev. 2012, 36, 1083-1104.
53. Gaze, W.H.; Zhang, L.; Abdouslam, N.A.; Hawkey, P.M.; Calvo-Bado, L.; Royle, J.; Brown, H.; Davis, S.; Kay, P.; Boxall, A.B.; et al. Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-Associated genes in the environment. ISME J. 2011, 5, 1253-1261.
54. Nardelli, M.; Scalzo, P.M.; Ramírez, M.S.; Quiroga, M.P.; Cassini, M.H.; Centrón, D. Class 1 integrons in environments with different degrees of urbanization. PLoS ONE 2012, 7, e39223.
55. British Society for Antimicrobial Chemotherapy. Standing Committee on Susceptibility Testing; Version 14.0; British Society for Antimicrobial Chemotherapy: Birmingham, UK, 2015.
56. Lai, H.T.; Chien, Y.H.; Lin, J.S. Long-Term transformation of oxolinic acid in water from an eel pond. Aquaculture 2008, 275, 96-101.
57. Zhang, Q.H.; Yang, W.N.; Ngo, H.H.; Guo, W.S.; Jin, P.K.; Dzakpasu, M.; Yang, S.J.;Wang, Q.;Wang, X.C.; Ao, D. Current status of urban wastewater treatment plants in China. Environ. Int. 2016, 92-93, 11-22.
58. Beaber, J.W.; Hochhut, B.; Waldor, M.K. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004, 427, 72-74.
59. Ubeda, C.; Maiques, E.; Knecht, E.; Lasa, I.; Novick, R.P.; Penadés, J.R. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in Staphylococci. Mol. Microbiol. 2005, 56, 836-844.
60. Davies, J.; Davies, D. Origins and Evolution of Antibiotic Resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417-433.
61. Garcillán-Barcia, M.P.; Alvarado, A.; de la Cruz, F. Identification of bacterial plasmids based on mobility and plasmid population biology. FEMS Microbiol. Rev. 2011, 35, 936-956.
62. Partridge, S.R. Analysis of antibiotic resistance regions in Gram-negative bacteria. FEMS Microbiol. Rev. 2011, 35, 820-855.
63. Zhang, T.; Zhang, X.X.; Ye, L. Plasmid metagenome reveals high levels of antibiotic resistance genes and mobile genetic elements inactivated sludge. PLoS ONE 2011, 6, e26041.
64. Farias, T.; de Menorval, L.C.; Zajac, J.; Rivera, A. Benzalkonium chloride and sulfamethoxazole adsorption onto natural clinoptilolite: Effect of time, ionic strength, pH and temperature. J. Colloid Interface Sci. 2011, 363, 465-475.
65. Xi, C.; Zhang, Y.; Marrs, C.F.; Wen, Y.; Carl, S.; Betsy, F.; Jerome, N. Prevalence of antibiotic resistance in drinking water treatment and distribution systems. Appl. Environ. Microbiol. 2009, 75, 5714-5718.
66. Figueira, V.; Vaz-Moreira, I.; Silva, M.; Manaia, C.M. Diversity and antibiotic resistance of Aeromonas spp. In drinking and waste water treatment plants. Water Res. 2011, 45, 5599-5611.
67. Stenström, T.A.; Okoh, A.I.; Adegoke, A.A. Antibiogram of environmental isolates of Acinetobacter calcoaceticus from Nkonkobe Municipality, South Africa. Fresenius Environ. Bull. 2016, 25, 3059-3065.
68. Brusselaers, N.; Vogelaers, D.; Blot, S. The rising problem of antimicrobial resistance in the intensive care unit. Ann. Intensive Care 2011, 1, 47.
69. Vizhi, S.K.; Senapathi, R. Evaluation of the perception, attitude and practice of self-medication among business students in 3 select Cities, South India. Int. J. Enterp. Innov. Manag. Stud. 2010, 1, 40-44.
70. Bennadi, D. Self-medication: A current challenge. J. Basic Clin. Pharm. 2014, 5, 19-23.
71. Pagán, J.A.; Ross, S.; Yau, J.; Polsky, D. Self-medication and health insurance coverage in Mexico. Health Policy 2006, 75, 170-177.
72. Pan, H.; Cui, B.; Zhang, D.; Farrar, J.; Law, F.; Ba-Thein, W. Prior knowledge, older age, and higher allowance are risk factors for self-medication with antibiotics among university students in southern China. PLoS ONE 2012, 7, e41314.
73. Luyt, C.E.; Bréchot, N.; Trouillet, J.L.; Chastre, J. Antibiotic stewardship in the intensive care unit. Crit. Care 2014, 18, 480.
74. Centers for Disease Control and Prevention, Office of Infectious Disease Antibiotic Resistance Threats in the United States, 2013. Available online: http://www.cdc.gov/drugresistance/threat-report-2013 (accessed on 28 June 2016).
75. Ventola, L. The Antibiotic Resistance Crisis. Pharm. Ther. 2015, 40, 277-284.
76. Senekal, M. Current resistance issues in antimicrobial therapy. CME 2010, 28, 54-57.
77. Perez, F.; Hujer, A.M.; Hujer, K.M.; Decker, B.K.; Rather, P.N.; Bonomo, R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51, 3471-3484.
78. Falagas, M.E.; Karageorgopoulos, D.E. Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram-Negative Bacilli: Need for International Harmonization in Terminology. Clin. Infect. Dis. 2008, 46, 1121-1122.
79. Adegoke, A.A.; Mvuyo, T.; Okoh, A.I. Ubiquitous Acinetobacter species as beneficial commensals but gradually being emboldened with antibiotic resistance genes. J. Basic Microbiol. 2012, 52, 1-8.
80. Shakibaie, M.R.; Adeli, S.; Salehi, M.H. Antibiotic resistance patterns and extended spectrum beta-lactamase production among Acinetobacter spp. isolated from anintensive care Unit of a hospital in Kerman, Iran. Antimicrob. Resist. Infect. Control 2012, 1, 1.
81. Sivaranjani, V.; Umadevi, S.; Srirangaraj, S.; Kali, A.; Seetha, K.S. Multi-drug resistant Acinetobacter species from various clinical samples in a tertiary care hospital from South India. AMJ 2013, 6, 697-700.
82. Souli, M.; Galani, I.; Giamarellou, H. Emergence of extensively drug-Resistant and pandrug-Resistant Gram-Negative bacilli in Europe. Eurosurveillance 2008, 13, 1-11.
83. Luangtongkum, T.; Jeon, B.; Han, J.; Plummer, P.; Logue, C.M.; Zhang, Q. Antibiotic resistance in Campylobacter: Emergence, transmission and persistence. Future Microbiol. 2009, 4, 189-200.
84. Lehtopolku, M.; Nakari, U.-M.; Kotilainen, P.; Huovinen, P.; Siitonen, A.; Hakanen, A.J. Antimicrobial Susceptibilities of Multidrug-Resistant Campylobacter jejuni and, C. coli Strains: In Vitro Activities of 20 Antimicrobial Agents. Antimicrob. Agents Chemother. 2010, 54, 1232-1236.
85. Wieczorek, K.; Osek, J. Antimicrobial Resistance Mechanisms among Campylobacter. BioMed Res. Int. 2013, 2013, 340605.
86. Sison, F.B.; Chaisowwong, W.; Alter, T.; Tiwananthagorn, S.; Pichpol, D.; Lampang, K.N.; Baumann, M.P.O.; Gölz, G. Loads and antimicrobial resistance. Poult. Sci. 2014, 93, 1270-1273.
87. Ngulukun, S.S.; Oboegbulem, S.S.; Fagbamila, I.; Barde, I. Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from chickens in a diagnostic laboratory. Afr. J. Microbiol. Res. 2005, 9, 2197-2201.
88. Garnacho-Montero, J.; Díaz-Martín, A.; García-Cabrera, P.; de Pipao, M.R.; Hernández-Caballero, C. Risk Factors for Fluconazole-Resistant Candidemia. Antimicrob. Agent Chemother. 2010, 54, 3149-3154.
89. Spampinato, C.; Leonardi, D. Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents. BioMed Res. Int. 2013, 2013, 204237.
90. Centers for Disease Control and Prevention. Antifungal Resistance. August 2016. Available online: http://www.cdc.gov/fungal/antifungal-resistance.html (accessed on 9 September 2016).
91. Liao, X.; Qiu, H.; Li, R.; Guo, F.; Liu, W.; Kang, M.; Kang, Y. Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients: An analysis from the China Survey of Candidiasis study. J. Crit. Care 2015, 30, 862.e1-862.e5.
92. Owotade, F.J.; Gulube, Z.; Ramla, S.; Patel, M. Antifungal susceptibility of Candida albicans isolated from the oral cavities of patients with HIV infection and cancer. SADJ 2016, 71, 8-11.
93. Kolar, M.; Bardon, J.; Chroma, M.; Hricova, K.; Stosova, T.; Sauer, P.; Koukalova, D. ESBL and AmpC beta-lactamase-producing Enterobacteriaceae in poultry in the Czech Republic. Vet. Med. 2010, 55, 119-124.
94. Tärnberg, M. Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae; Linköping University Medical Dissertations; Linköping University: Linköping, Sweden, 2012.
95. Zurfluh, K.; Hächler, H.; Nöesch-Inderbinen, M.; Stephan, R. Characteristics of Extended-Spectrum-Lactamase-And Carbapenemase-Producing Enterobacteriaceae Isolates from Rivers and Lakes in Switzerland. Appl. Environ. Microbiol. 2013, 79, 3021-3026.
96. Kandeel, A. Prevalence and risk factors of extended-spectrum-lactamases producing Enterobacteriaceae in a general hospital in Saudi Arabia. J. Microbiol. Infect. Dis. 2014, 4, 50-54.
97. Schmiedel, J.; Falgenhauer, L.; Domann, E.; Bauerfeind, R.; Prenger-Berninghoff, E.; Imirzalioglu, C.; Chakraborty, T. Multiresistant extended-spectrum-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC Microbiol. 2014, 14, 187.
98. Pilmis, B.; Delory, T.; Groh, M.;Weiss, E.; Emirian, A.; Lecuyer, H.; Lesprit, P.; Zahar, J.-R. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: Are carbapenem alternatives achievable in daily practice? Int. J. Infect. Dis. 2015, 39, 62-67.
99. Lukac, P.J.; Bonomo, R.A.; Logan, L.K. Extended-Spectrum-Lactamase-Producing Enterobacteriaceae in Children: Old Foe, Emerging Threat. Clin. Infect. Dis. 2015, 60, 1389-1397.
100. Willemsen, I.; Oome, S.; Verhulst, C.; Pettersson, A.; Verduin, K.; Kluytmans, J. Trends in Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae and ESBL Genes in a Dutch Teaching Hospital, Measured in 5 Yearly Point Prevalence Surveys (2010-2014). PLoS ONE 2015, 10, e0141765.
101. Sahlström, L.; Rehbinder, V.; Albihn, A.; Aspan, A.; Bengtsson, B. Vancomycin resistant enterococci (VRE) in Swedish sewage sludge. Acta Vet. Scand. 2009, 51, 24.
102. Molton, J.S.; Tambyah, P.A.; Ang, B.S.P.; Ling, M.L.; Fisher, D.A. The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective from Asia. Clin. Infect. Dis. 2013, 56, 1310-1318.
103. Varela, A.R.; Ferro, G.; Vredenburg, J.; Yanik, M.; Vieira, L.; Rizzo, L.; Lameiras, C.; Manaia, C.M. Vancomycin resistant enterococci: From the hospital effluent to the urban wastewater treatment plant. Sci. Total Environ. 2013, 450-451, 155-161.
104. Abebe, W.; Endris, M.; Tiruneh, M.; Moges, F. Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: A cross-sectional study. BMC Public Health 2014, 14, 185.
105. Goldstein, R.E.R.; Micallef, S.A.; Gibbs, S.G.; George, A.; Claye, E.; Sapkota, E.; Josepha, S.W.; Sapkota, A.R. Detection of vancomycin-resistant enterococci (VRE) at four, U.S. wastewater treatment plants that provide effluent for reuse. Sci. Total Environ. 2014, 466-467, 404-411.
106. Daniel, D.S.; Lee, S.M.; Dykes, G.A.; Rahman, S. Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia. Appl. Environ. Microbiol. 2015, 81, 6090-6097.
107. Lister, P.D.;Wolter, D.J.; Hanson, N.D. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 2009, 22, 582-610.
108. Hirsch, E.B.; Tam, V.H. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev. Pharmacoecon. Outcomes Res. 2010, 10, 441-451.
109. Akingbade, O.A.; Balogun, S.A.; Ojo, D.A.; Afolabi, R.O.; Motayo, B.O.; Okerentugba, P.O.; Okonko, I.O. Plasmid Profile Analysis of Multidrug Resistant Pseudomonas aeruginosa isolated from Wound Infections in South West, Nigeria. World Appl. Sci. J. 2012, 20, 766-775.
110. Meletis, G.; Bagkeri, M. Pseudomonas aeruginosa: Multi-Drug-Resistance Development and Treatment Options; INTECH: Vienna, Austria, 2013.
111. Rizvi, M.; Ahmad, J.; Khan, F.; Shukla, I.; Malik, A.; Sami, H. Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa. Australas. Med. J. 2015, 8, 1-6.
112. Yayan, J.; Ghebremedhin, B.; Rasche, K. Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period. PLoS ONE 2015, 10, e0139836.
113. Mijovic, G.; Andric, B.; Terzic, D.; Lopicic, M.; Dupanovic, B. Antibiotic susceptibility of salmonella spp.: A comparison of two surveys with a 5 years interval. J. IMAB Annu. Proc. 2012, 18.
114. Fallah, S.H.; Asgharpour, F.; Naderian, Z.; Moulana, Z. Isolation and Determination of Antibiotic Resistance Patterns in Non-Typhoid Salmonella spp. isolated from chicken. Int. J. Enteric Pathog. 2013, 1, 17-21.
115. Al Ayed, M.S.Z. Prevalence of nontyphoidal Salmonella serotypes and the antimicrobial resistance in pediatric patients in Najran Region, Saudi Arabia. Int. J. Curr. Microbiol. App. Sci. 2014, 3, 103-107.
116. Khairy, R.M.M. Anti-Microbial Resistance of Non-Typhoid Salmonella in Egypt. Ferment. Technol. 2015, 4, 123.
117. Eguale, T.; Gebreyes, W.A.; Asrat, D.; Alemayehu, H.; Gunn, J.S.; Engidawork, E. Non-Typhoidal Salmonella serotypes, antimicrobial resistance and co-infection with parasites among patients with diarrhea and other gastrointestinal complaints in Addis Ababa, Ethiopia. BMC Infect. Dis 2015, 15, 497.
118. Hsu, C.Y.; Hsu, B.M.; Ji, B.M.; Chen, J.S.; Hsu, T.K.; Ji, D.D.; Tseng, S.F.; Chiu, Y.S.; Kao, P.M.; Huang, Y.L. Antibiotic resistance pattern and gene expression of non-Typhoid Salmonella in riversheds. Environ. Sci. Pollut. Res. 2015, 22, 7843-7850.
119. Liang, Z.; Ke, B.; Deng, X.; Liang, J.; Ran, L.; Lu, L.; He, D.; Huang, Q.; Ke, C.; Li, Z.; et al. Serotypes, seasonal trends, and antibiotic resistance of non-Typhoidal Salmonella from human patients in Guangdong Province, China, 2009-2012. BMC Infect. Dis. 2015, 15, 53.
120. Tu, L.T.; Hoang, N.V.; Cuong, N.V.; Campbell, J.; Bryant, J.E.; Hoa, N.T.; Kiet, B.T.; Thompson, C.; Duy, D.T.; Phat, V.V.; et al. High levels of contamination and antimicrobial-resistant non-Typhoidal Salmonella serovars on pig and poultry farms in the Mekong Delta of Vietnam. Epidemiol. Infect. 2015, 143, 3074-3086.
121. Nagshetty, K.; Channappa, S.T.; Gaddad, S.M. Antimicrobial susceptibility of Salmonella typhi in India. J. Infect. Dev. Ctries 2010, 4, 70-73.
122. Mandal, S.; DebMandal, M.; Pal, N.K. Antibiotic Resistance of Salmonella enterica Serovar Typhi in Kolkata, India, and In Vitro Experiments on Effect of Combined Chemotherapy. Sci. World J. 2012, 2012, 454059.
123. Adabara, N.U.; Ezugwu, B.U.; Momojimoh, A.; Madzu, A.; Hashiimu, Z.; Damisa, D. The Prevalence and Antibiotic Susceptibility Pattern of Salmonella typhi among Patients Attending a Military Hospital in Minna, Nigeria. Adv. Prev. Med. 2012, 2012, 875419.
124. Ugboko, H.; de, N. Mechanisms of Antibiotic resistance in Salmonella typhi. Int. J. Curr. Microbiol. Appl. Sci. 2014, 3, 461-476.
125. Balcázar, J.L.; Subirats, J.; Borrego, C.M. The role of biofilms as environmental reservoirs of antibiotic resistance. Front. Microbiol. 2015, 6, 1216.
126. Holcomb, H.G.; Durbin, K.J.; Cho, M.; Choi, K.J.; Darling, N.D.; Angerio, A.D. Ethicillin-resistant Staphylococcus aureus as a threat to public health: A cellular approach. GU J. Health Sci. 2008, 5, 2.
127. Adegoke, A.A.; Komolafe, A.O. Multidrug Resistant Staphylococcus aureus in Clinical Cases in Ile-Ife, Southwest Nigeria. Int. J. Med. Med. Sci. 2009, 1, 68-72.
128. Frieden, T.R. Maximizing infection prevention in the next decade: Defining the unacceptable. Infect. Control Hosp. Epidemiol. 2010, 31, S1-S3.
129. Johnson, A.P. Methicillin-resistant Staphylococcus aureus: The European landscape. Antimicrob. Chemother. 2011, 66 (Suppl. S4), iv43-iv48.
130. Neel, R. Multidrug resistance of isolates of methicillin resistant Staphylococcus aureus (MRSA) in paper currency notes from restaurants and hotels in Lusaka in Zambia. Int. J. Pharm. Pharm. Sci. 2012, 5, 363-366.
131. Adegoke, A.A.; Okoh, A.I. Species diversity and antibiotic resistance properties of Staphylococcus of farm animal origin in Nkonkobe Municipality. Folia Microbiol. 2014, 59, 133-140.
132. Reinert, R.R.; Reinert, S.; van der Linden, M.; Cil, M.; Al-Lahham, A.; Appelbaum, P. Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003. Antimicrob. Agents Chemother. 2005, 29, 2903-2913.
133. Dagan, R.; Klugman, K. Impact of Conjugate Pneumococcal Vaccine on Antibiotic Resistance. In Pneumococcal Vaccines; Siber, G., Klugman, K., Mäkelä, P., Eds.; ASM Press: Washington, DC, USA, 2008; pp. 369-385.
134. Vila-Corcoles, A.; Bejarano-Romero, F.; Salsench, E. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-Acquired pneumonia. BMC Infect. Dis. 2009, 9, 36.
135. Chawla, K.; Gurung, B.; Mukhopadhyay, C.; Bairy, I. Reporting emerging resistance of Streptococcus pneumoniae from India. J. Glob. Infect. Dis. 2010, 2, 10-14.
136. Jenkins, T.C.; Sakai, J.; Knepper, B.C.; Swartwood, C.J. Risk Factors for Drug-resistant Streptococcus pneumoniae and Antibiotic Prescribing Practices in Outpatient Community-Acquired Pneumonia. Acad. Emerg. Med. 2012, 19, 703-706.
137. Raju, A.; Santos, E.R.; Bakota, E.V.; Yang, B.; Arafat, R.R. Susceptibility Profile of Drug-Resistant Streptococcus pneumoniae Based on ELR. ISDS 2015 Conference Abstracts Online. J. Public Health Inform. 2015, 8, e154.
138. Kim, L.; McGee, L.; Tomczyk, S.; Beall, B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre-And post-conjugate vaccine eras: A United States perspective. Clin. Microbiol. Rev. 2016, 29, 525-552.
139. Zignol, M.; Dean, A.S.; Falzon, D.; van Gemert, W.; Wright, A.; van Deun, A.; Portaels, F.; Laszlo, A.; Espinal, M.A.; Pablos-Méndez, A.; et al. Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance. N. Engl. J. Med. 2016, 375, 1081-1089.
140. Udwadia, Z.F.; Amale, R.A.; Ajbani, K.K.; Rodrigues, C. Totally Drug-Resistant Tuberculosis in India. Clin. Infect. Dis. 2012, 54, 579-581.
141. Klopper, M.; Warren, R.M.; Hayes, C.; van Pittius, N.C.G.; Streicher, E.M.; Möller, B.; Sirgel, F.A.; Mamisa, C.-N.; Hoosain, E.; Coetzee, G.; et al. Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa. Emerg. Infect. Dis. 2013, 19, 449-455.
142. Velayati, A.A.; Farnia, P.; Masjedi, M.R. The totally drug resistant tuberculosis (TDR-TB). Int. J. Clin. Exp. Med. 2013, 6, 307-309.
143. Parida, S.K.; Axelsson-Robertson, R.; Rao, M.V.; Singh, N.; Master, I.; Lutckii, A.; Keshavjee, S.; Andersson, J.; Zumla, A.; Maeurer, M. Totally drug-resistant tuberculosis and adjunct therapies (Review). J. Intern. Med. 2015, 277, 388-405.
144. Liu, Z.;Wang, W.; Zhu, Y.; Gong, Q.; Yu, W.; Lu, X. Antibiotics at subinhibitory concentrations improve the quorum sensing behavior of Chromobacterium violaceum. FEMS Microbiol. Lett. 2013, 341, 37-44.
145. Subhadra, B.; Oh, M.H.; Choi, C.H. Quorum sensing in Acinetobacter: With special emphasis on antibiotic resistance, biofilm formation and quorum quenching. AIMS Microbiol. 2016, 2, 27-41.
146. Anderson, G.G.; OToole, G.A. Innate and Induced Resistance Mechanisms of Bacterial Biofilms. Curr. Top. Microbiol. Immunol. 2008, 322, 85-105.
147. Andersson, D.I.; Hughes, D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 2014, 12, 465-478.
148. Stewart, P.S.; Costerton, J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358, 135-138.
149. Anderl, J.N.; Franklin, M.J.; Stewart, P.S. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 2000, 44, 1818-1824.
150. Røder, H.L.; Sørensen, S.J.; Burmølle, M. Studying bacterial multispecies biofilms: Where to start? Trends Microbiol. 2016, 24, 503-513.
151. Weitao, T. Multicellularity of a unicellular organism in response to DNA replication stress. Res. Microbiol. 2009, 160, 87-88.
152. Kostakioti, M.; Hadjifrangiskou, M.; Hultgren, S.J. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the post antibiotic era. Cold Spring Harbor Perspect. Med. 2013, 3, a010306.
153. Mulcahy, L.R.; Isabella, V.M.; Lewis, K. Pseudomonas aeruginosa biofilms in disease. Microb. Ecol. 2014, 68, 1-12.
154. Singh, R.; Ray, P. Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance. Future Microbiol. 2014, 9, 669-681.
155. Canton, R.; Morosini, M. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol. Rev. 2011, 35, 977-991.
156. Davies, J.A.; Harrison, J.J.; Marques, L.L.; Foglia, G.R.; Stremick, C.A.; Storey, D.G.; Turner, R.J.; Olson, M.E.; Ceri, H. The GacS sensor kinase controls phenotypic reversion of small colony variants isolated from biofilms of Pseudomonas aeruginosa PA14. FEMS Microbiol. Ecol. 2007, 59, 32-46.
157. Paraje, M.G. Antimicrobial Resistance in Biofilms. In Science Against Microbial Pathogens: Communicating Current Research and Technological Advances; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2011; pp. 736-744.
158. Anderson, S.W.; Stapp, J.R.; Burns, J.L.; Qin, X. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J. Clin. Microbiol. 2007, 45, 529-535.
159. Wright, G.D. The antibiotic resistome: The nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 2007, 5, 175-186.
160. Stenström, T.A.; Seidu, R.; Ekane, N.; Zurbrögg, C. Microbial Exposure and Health Assessments in Sanitation Technologies and Systems; EcoSanRes Series; Stockholm Environment Institute (SEI): Stockholm, Sweden, 2011.
161. Scallan, E.; Hoekstra, R.M.; Angulo, F.J.; Tauxe, R.V.;Widdowson, M.A.; Roy, S.L.; Jones, J.L.; Griffin, P.M. Foodborne illness acquired in the United States-Major pathogens. Emerg. Infect. Dis. 2011, 17, 7-15.
162. Ashbolt, N.J.; Amezquita, A.; Backhaus, T.; Borrelio, P.; Brant, K.K.; Collignon, P.; Coors, A.; Finley, R.; Gaze, W.H.; Heberer, T.; et al. Human health risk assessment (HHRA) for environmental development and transfer of antibiotic resistance. Environ. Health Perspect. 2013, 121, 993-1001.
163. Michael, I.; Rizzo, L.; McArdell, C.S.; Manaia, C.M.; Merlin, C.; Schwartz, T.; Dagot, C.; Fatta-Kassinos, D. Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review. Water Res. 2013, 47, 957-995.
164. Shakya, R.; Thapa, P.; Saha, R.N. In vitro and in vivo evaluation of gastro retentive floating drug delivery system of ofloxacin. Asian J. Pharm. Sci. 2013, 8, 191-198.
165. Ling, L.L.; Schneider, T.; Peoples, A.J.; Spurring, A.L.; Engels, I. A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517, 455-459.
166. Palombo, E.A. Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid. Based Complement. Altern. Med. 2011, 2011, 680354.
167. Adak, S.; Upadrasta, L.; Kumar, S.P.J.; Soni, R.; Banerjee, R. Quorum Quenching-An Alternative Antimicrobial Therapeutics. Available online: http://www.formatex.info/microbiology3/book/586-593. pdf (accessed on 11 October 2016).
168. Tang, K.; Zhang, X.H. Quorum Quenching Agents: Resources for Antivirulence Therapy. Mar. Drugs 2014, 12, 3245-3282.
169. Bordi, C.; de Bentzmann, S. Hacking into bacterial biofilms: A new therapeutic challenge. Ann. Intensive Care 2011, 1, 19.
170. World Health Organization. Step-by-Step Approach for Development and Implementation of Hospital Antibiotic Policy and Standard Treatment Guidelines 2011; World Health Organization: Geneva, Switzerland, 2011.